Rituximab to Abbreviate Plasma Exchange in Anti-CFH (Complement Factor H) Antibody Mediated Atypical HUS. IJKD. 2019;13(2):134-138. Accessed May 18, 2024. https://www.ijkd.org/index.php/ijkd/article/view/4138